Atlas Trials

Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC

Clinical trial NCT04105153 · COMPLETED

Trial details

NCT number
NCT04105153
Sponsor
Thoraxklinik-Heidelberg gGmbH
Status
COMPLETED
Study type
OBSERVATIONAL
EGFR Positive Non-small Cell Lung Cancer
Start date
2019-04-15
Primary completion
2019-12-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.